Dr. Martina Flammer is the Chief Medical Officer at Insmed, Inc., where she has been shaping the company's strategy since December 2019. With an M.B.A. from NYU Stern School of Business and an M.D. from the University of Vienna Medical...

Dr. Martina Flammer is the Chief Medical Officer at Insmed, Inc., where she has been shaping the company's strategy since December 2019. With an M.B.A. from NYU Stern School of Business and an M.D. from the University of Vienna Medical School, she's no stranger to demanding roles. Before Insmed, she held high-ranking positions at Boehringer Ingelheim, where she led corporate strategy and worked in clinical development. Dr. Flammer has over 20 years of experience bridging medicine and the business side of pharmaceuticals, making her a critical asset in the biopharma space. Her approach emphasizes performance, aligning the company's interests with those of shareholders. Under her leadership, Insmed has focused on innovative therapies, showing commitment to higher patient outcomes and industry standards. Recently, her annual compensation in 2023 was reported at around $4.2 million, largely tied to performance-based metrics. This reflects a larger trend where companies reward executives for hitting ambitious goals.